First Manhattan’s CollPlant Biotechnologies CLGN Stock Holding History

First Manhattan’s Portfolio CLGN Stock Details CLGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-100	Closed	-$816	–	1499
2023 Q2	$816	Hold	100	–	–	﹤0.01%	1350
2023 Q1	$702	Hold	100	–	–	﹤0.01%	1448
2022 Q4	$835	Hold	100	–	–	﹤0.01%	1591
2022 Q3	$0	Hold	100	–	–	﹤0.01%	1531
2022 Q2	$0	Hold	100	–	–	﹤0.01%	1557
2022 Q1	$1K	Hold	100	–	–	﹤0.01%	1524
2021 Q4	$1K	Buy	+100	New	+$1.78K	﹤0.01%	1518

Other funds holding CLGN

RAM

Roumell Asset Management Chevy Chase, Maryland $53.3M AUM 8.91% 1-Year Est. Return

Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return

SDJVC

St. Denis J. Villere & Co New Orleans, Louisiana $907M AUM 10.61% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

BFEC

Benjamin F. Edwards & Company St. Louis, Missouri $5.69B AUM 15.37% 1-Year Est. Return

Zurich Cantonal Bank Zurich, Switzerland $46B AUM 27.59% 1-Year Est. Return

Parallel Advisors San Francisco, California $5.56B AUM 17.89% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

First Manhattan's CLGN Position: Q3 2023 in Review

First Manhattan sold out of CollPlant Biotechnologies (CLGN) in Q3 2023, closing a stake of 100 shares — an estimated $816 sold.

First Manhattan first reported a position in CLGN in Q4 2021 and held it in 7 quarters. The position peaked at $1K in Q1 2022. 18 funds tracked by Wall St. Rank hold CLGN as of Q3 2023.

First Manhattan reported no remaining CollPlant Biotechnologies position as of Q3 2023 after selling out during the quarter.
First Manhattan sold 100 CollPlant Biotechnologies shares in Q3 2023, an estimated $816.
First Manhattan first reported a position in CollPlant Biotechnologies in Q4 2021 and held it in 7 quarters.
First Manhattan's CollPlant Biotechnologies position peaked at $1K in Q1 2022.
18 funds tracked by Wall St. Rank held CollPlant Biotechnologies as of Q3 2023.

Based on First Manhattan's 13F filing for Q3 2023, filed 14 Nov 2023.